TNH Approves VND 220B Convertible Bond at 16% as Losses Widen

Overview

Tập đoàn Bệnh viện TNH (HOSE: TNH) held its first extraordinary shareholder meeting of 2026 on 6 November, approving the issuance of up to VND 220 billion in convertible bonds carrying a 16% annual coupon. The approval comes as the hospital operator remains loss-making, with a 9M2026 net loss of VND 117 billion against VND 75 billion a year earlier, despite consolidated revenue rising 27% to VND 461 billion.

Key Facts

• Convertible bond issuance approved at up to VND 220 billion, roughly USD 8.8 million at the stated magnitude.
• Coupon set at 16% per annum, with principal and interest paid in full at the end of a two-year term rather than quarterly.
• Management said the 16% rate is benchmarked against TNH’s secured bank borrowing at about 11% per year; the bonds are unsecured.
• 9M2026 consolidated revenue reached VND 461 billion, up 27% year on year.
• 9M2026 net loss widened to VND 117 billion from VND 75 billion in the same period of 2025.
• Gross profit fell 33% to approximately VND 12 billion, compressing the gross margin.
• Bệnh viện TNH Việt Yên posted VND 67 billion in 9M revenue, up 66%, with Q3 bed occupancy at 104% of 150 registered beds.
• Bệnh viện TNH Lạng Sơn, operating since 15 July 2026, generated VND 14 billion in roughly 2.5 months.

What Happened

At the 6 November meeting, shareholders of CTCP Tập đoàn Bệnh viện TNH approved a plan to issue up to VND 220 billion of convertible bonds at a 16% annual interest rate. Company leadership explained the pricing by comparing it with TNH’s existing secured bank loans, which carry rates of about 11% per year, noting that the bonds are unsecured. In exchange for the higher coupon, the entire principal and interest are scheduled for settlement at the end of the two-year term instead of quarterly payments. The filing does not disclose the conversion price, the investor base, or the use of proceeds.

Management also presented operating detail on the hospital network. Bệnh viện Quốc tế Thái Nguyên grew revenue 6% and Bệnh viện TNH Phổ Yên 9% over nine months, a recovery after two to three years of decline from pandemic-era peaks. Bệnh viện TNH Việt Yên lifted revenue 66% to VND 67 billion, with outpatient visits up 45% and inpatient admissions up 64%; its EBITDA improved from negative VND 16 billion to negative VND 7 billion and turned positive in July and August when monthly revenue exceeded VND 9 billion. Bệnh viện TNH Lạng Sơn, open since 15 July 2026, recorded VND 14 billion in revenue over about 2.5 months at 100-110% occupancy of 98 registered beds.

Market Context

TNH closed at VND 6,510 on 6 November 2026 on HOSE, the same day as the meeting. The stock sits in the small-cap healthcare segment of the Vietnamese market, where hospital operators have traded on expansion pipelines rather than near-term earnings. TNH’s multi-year build-out of new facilities has kept the company in losses even as topline growth accelerates, a pattern that has weighed on sentiment across the listed private-hospital group. The 16% coupon is well above the roughly 11% secured bank rate cited by management, reflecting the unsecured structure and the company’s current loss position.

Strategic Significance

The bond is best read as bridge capital for a network still absorbing the fixed costs of new hospitals. Việt Yên’s swing to positive EBITDA at monthly revenue above VND 9 billion is the clearest evidence that the model can reach operating breakeven at scale, and Lạng Sơn’s faster early ramp suggests the template travels. The trade-off is cost: a 16% unsecured coupon on VND 220 billion adds roughly VND 35 billion of annual interest, deferred to maturity, which pressures the path back to net profit if the new facilities do not keep compounding. Deferring all payment to the end of the two-year term concentrates refinancing and conversion risk into a single date, making the conversion terms and the equity dilution they imply the central variable for existing holders.

What to Watch

• Disclosure of the bond’s conversion price, investor list, and use of proceeds in the next TNH filing.
• Q4 2026 and full-year 2026 results, particularly whether Việt Yên sustains positive monthly EBITDA through year-end.
• Progress on licensing Việt Yên from 150 to 200 registered beds and Lạng Sơn from 98 to 145 beds.
• Whether TNH secures additional bank facilities or equity to cover the VND 220 billion maturity at the end of the two-year term.
• Gross margin trend after the 33% decline in 9M2026 gross profit.